Focus on patients receiving long-term antimicrobial treatments for lyme borreliosis: No lyme but mostly mental disorders.
Antimicrobials
Lyme borreliosis
Somatic symptoms and related disorders
Journal
Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
15
05
2020
revised:
12
07
2020
accepted:
15
10
2020
pubmed:
26
10
2020
medline:
27
8
2021
entrez:
25
10
2020
Statut:
ppublish
Résumé
Overdiagnosis of lyme borreliosis leads to unnecessary and increasingly common antimicrobial treatments. We aimed to evaluate patients receiving long-term antimicrobial treatment for lyme borreliosis. We included patients referred to a Parisian teaching hospital between January 1st, 2014 and June 30th, 2019, with a presumed diagnosis of lyme borreliosis for which they were treated with antimicrobials for at least 6 months. Fifteen patients were included (11 women and mean age 44 years). The mean antimicrobial treatment duration was 476 days (180-942). The mean number of antimicrobials was 6.8 per patient (1-18). None of the 15 patients had lyme borreliosis. Nine patients were diagnosed with a mental disorder. Overdiagnosis and overtreatment of lyme borreliosis put patients at risk of undiagnosed illnesses and multiple adverse effects of unjustified treatments. The clinical management of such patients requires a comprehensive approach including expertise in mental disorders.
Identifiants
pubmed: 33098950
pii: S0399-077X(20)30758-7
doi: 10.1016/j.medmal.2020.10.018
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
300-303Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.